HASTANE ENFEKSİYONU ARAŞTIRMA LABORATUVARINDA SAPTANAN RETROSPEKTİF SONUÇLARIN DEĞERLENDİRİLMESİ

Öz

Amaç: Hastaneler, sağlık hizmeti sunumu sırasında potansiyel enfeksiyon riski kaynağıdırlar. Vankomisine dirençli enterokoklar (VRE) ve karbapenemaz üreten Gram-negatif çomaklar, kalıcı kolonizasyona ve çok ilaca dirençli bakteriyel enfeksiyonlara neden olduğundan hastane enfeksiyonlarında önemlidirler. Bu çalışmada, 1 Ocak 2020 / 31 Aralık 2020 tarihleri arasında kliniklerde yatan hastaların rektal sürüntü örneklerinin hastane enfeksiyonu etkeni olan VRE ve karbapenem-dirençli (KD) Gram-negatif çomaklar açısından retrospektif olarak değerlendirmesi amaçlanmıştır. Gereç ve Yöntem: Hastanede yatan hastaların Hastane enfeksiyon Araştırma Laboratuvarı’na gönderilen rektal sürüntü örneklerinden KD Gram-negatif çomaklar ve VRE’yi izole etmek ve tanımlamak için standart klinik laboratuvar yöntemleri kullanılmıştır. Bulgular: İncelenen 2688 örneğin 777’sinde (%28,9) üreme olmuştur. Üreyen bakterilerin 627’si (%80,7) VRE ve 150’si (%19,3) KD Gram-negatif çomaklar olarak tanımlanmıştır. Bunlardan 75’i KD K. pneumonia; 7’si KD K. oxytoca; 26’sı KD Enterobacter türleri; 2’si KD E. coli; ve 40 suş KD Acinetobacter türü olarak belirlenmiştir. Vankomisine dirençli enterokoklar en sıklıkla dahiliye servisinde (%56,3 - 353/627) ve pediatrik yoğun bakım-yenidoğan servisinde (%37,6 - 236/627) tespit edilmiştir. Pediatri servislerinde toplam 296 bakterinin 146’sı VRE olarak tanımlanmıştır. Sonuç: Hastane enfeksiyonlarının kontrolünde yapılan sürveyans çalışmaları ile her sağlık kuruluşu kendi hastane florasını oluşturan mikroorganizmaları, direnç durumlarını ve dağılımlarını belirlemektedir. Elde edilen verilerin hastanelerin enfeksiyon kontrol süreçlerinde katkı sağlayacağı düşünülmektedir.

Anahtar Kelimeler

• Hastane enfeksiyonu
• vankomisine dirençli enterokoklar
• karbapeneme dirençli bakteriler
• enfeksiyon kontrol önlemleri.

AN EVALUATION OF RETROSPECTIVE RESULTS DETECTED IN THE HOSPITAL INFECTION RESEARCH LABORATORY

Öz

Objective: Hospitals are a potential source of infection risk during healthcare delivery. Since vancomycin-resistant enterococci (VRE) and carbapenemase producing Gram-negative rods cause persistent colonization and multi-drug resistant bacterial infections, they are important in nosocomial infections. In this study, we aimed to retrospectively evaluate rectal swab samples of patients hospitalized in the clinics in terms of VRE and carbapenem- resistant (CR) Gram-negative rods as nosocomial infection agents between 1st January 2020 and 31st December 2020. Materials and Methods: Standard clinical laboratory methods were used to isolate and identify CR Gram-negative rods and VRE from rectal swab samples of hospitalized patients sent to our Hospital Infection Research Laboratory. Results: There was growth in 777 (28.9%) of 2688 samples examined. Of the bacteria that grew, 627 (80.7%) were defined as VRE, and 150 (19.3%) as Gram-negative rods resistant to carbapenem. Seventy-five of these were defined as CR K. pneumoniae: 7 as CR K. oxytoca: 26 as CR Enterobacter species: 2 as CR E. coli: and 40 as CR Acinetobacter species. Vancomycin-resistant enterococci were detected most frequently in the internal medicine ward (56.3% - 353/627) and pediatric intensive care-neonatal ward (37.6% - 236/627). In pediatric services, 146 of total 296 bacteria isolated were identified as VRE. Conclusion: With the surveillance studies carried out in the control of hospital infections, each health institution determines the microorganisms that make up its own hospital flora, their resistance status and their distribution. It is thought that the data we obtain will contribute to the infection control processes of the hospitals.

Anahtar Kelimeler

• Nosocomial infection
• vancomycin-resistant enterococci,
• carbapenem-resistant bacteria
• infection control measures

Kaynakça

1. 1. Karahocagil MK, Yaman G, Goktas U, Sunnetcioglu M, Cikman A, Bilici A, et al. Hastane enfeksiyon etkenlerinin ve direnç profillerinin belirlenmesi. Van Tıp Derg 2011;18(1):27-32. google scholar
2. 2. Sievert DM, Ricks P, Edward JR, Schneider A, Patel J, Srinivasan A, et al. Antimicrobial-resistant pathogens associated with healthcare associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 2013;34(1):1-14. [Crossref] google scholar
3. 3. Aydin F. Ülkemizde mevcut duruma eleştirel bir yaklaşım: Klinik mikrobiyoloji uzmanı gözüyle enfeksiyon kontrol yönetmeliği. 2. Ulusal Klinik Mikrobiyoloji Kongresi; 2013 November 10-13; Antalya, Türkiye, 2013, p.157-8. google scholar
4. 4. Sinatra I, Carubia L, Marchese V, Aprea L, Alessandro ND, Mammina C, et al. Prevalence survey of healthcare-associated infections and antimicrobial use at the University Hospital “Paolo Giaccone”, Palermo, Italy. J Prev Med Hyg 2013;54(4):200-4. google scholar
5. 5. Ducel G, Fabry J, Nicolle L. Prevention of hospital-acquired infections. A practical guide. 2nd edition. World Health Organization. https://apps.who.int/iris/ handle/10665/67350?show=full google scholar
6. 6. Ahmed MO, Baptiste KE. Vancomycin-resistant enterococci: A review of antimicrobial resistance mechanisms and perspectives of human and animal health. Microbial Drug Resistance 2018;24(5):590-606. [Crossref] google scholar
7. 7. Bilgehan A, Kayabas U. Yoğun bakım birimlerinde dirençli infeksiyon sorunu. Klimik Derg 2001;14(2):83-7. google scholar
8. 8. Doi Y. Treatment options for carbapenem-resistant gramnegative bacterial infections. Clin Infect Dis 2019;69(Supply 7):S565-75. [Crossref] google scholar

9. 9. Kahraman EP, Toptan H, Otlu B, Köroğlu M, Altindiş M. Karbapenemaz üreten Klebsiella pneumoniae suşlarında blaOXA-48-benzeri genlerin araştırılması [Investigation of blaOXA-48-like genes in carbapenemase producing Klebsiella spp. isolates]. Mikrobiyol Bul 2019;53(2):134-43. [Crossref] google scholar
10. 10. Şahin AR, Doğruer D, Nazik S, Aktemur A, Öksüz H, Aral M, et al. Hastane kökenli patojenlerde artan antimikrobiyal direnç sorunu: Acinetobacter baumannii [Increasing antimicrobial resistance problem of nosocomial pathogens: Acinetobacter baumannii]. OTJHS 2019;4(2):156-69. [Crossref] google scholar
11. 11. David S, Reuter S, Harris SR, Glasner C, Feltwell T, Argimon S, et al. Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread. Nat Microbiol 2019;4(11):1919-29. [Crossref] google scholar
12. 12. Liu Q, Liu L, Li Y, Ch Xia , Yan Q, Liu W-E . Fecal carriage and epidemiology of carbapenem-resistant enterobacteriaceae among hospitalized patients in a university hospital. Infect Drug Resist 2019;12:3935-42. [Crossref] google scholar
13. 13. Procop GW, Church DL, Hall GS, Janda WM, Koneman EW, Schreckenberger PC, et al. Gram positive cocci. In Koneman’s Color Atlas and Textbook of Diagnostic Microbiology. Lippincot Williams & Wilkins-China, Seventh Edition, Chapter 13, 2017, p:733-843. google scholar
14. 14. Bryskier A, Antimicrobial Agents. In: Carbapenems. ASM Press, Washington, USA, 2005, p:269-318. [Crossref] google scholar
15. 15. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: 28th Edition, CLSI supplement M100, Wayne, PA, 2018. https://clsi. org/standards/products/microbiology/documents/m100/ google scholar
16. 16. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standards, 7th Edition, CLSI Standart M7-A7, Wayne, USA, 2006. https://clsi.org/ standards/products/microbiology/documents/m07/ google scholar
17. 17. Procop GW, Church DL, Hall GS, Janda WM, Koneman EW, Schreckenberger PC, et al. The Enterobacteriaceae. In: Koneman’s Color Atlas and Textbook of Diagnostic Microbiology. 7th Edition, Lippincot Williams & Wilkins-China, 2017, p:213-315. google scholar
18. 18. Procop GW, Church DL, Hall GS, Janda WM, Koneman EW, Schreckenberger PC, et al. The Nonfermentative Gramnegative bacilli. In: Koneman’s Color Atlas and Textbook of Diagnostic Microbiology. 7th Edition, Lippincot Williams & Wilkins-China, 2017, p:316-431. google scholar
19. 19. Procop GW, Church DL, Hall GS, Janda WM, Koneman EW, Schreckenberger PC, et al. Antimicrobial testing. In: Koneman’s Color Atlas and Textbook of Diagnostic Microbiology,7th Edition, Lippincot Williams & Wilkins-China, 2017, p:1074-171. google scholar
20. 20. Rai V, Gan CHS, Rosenthal VD, Hasan MSH, Lum LCHS, Mansor M, et al. Device-associated infection and mortality rates, bacterial resistance, and length of stay in hospitals of Malaysia: International Nosocomial Infection Control Consortium (INICC)’s findings. Can J Infect Control 2016;31(2):107-12. google scholar
21. 21. World Health Organization (WHO) Guidelines on hand hygiene in health care: a summary. 2009. https://apps.who. int/iris/handle/10665/70126 google scholar
22. 22. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Mikrobiol Rev 2000;13(4):686-707. [Crossref] google scholar
23. 23. Reyes K, Bardossy AC, Zervos M. Vancomycin-resistant enterococci: epidemiology, infection prevention, and control. Infect Dis Clin North Am 2016;30(4):953-65. [Crossref] google scholar
24. 24. Chiang HY, Perencevich EN, Nair R, Nelson RE, Samore M, Khader K, et al. Incidence and outcomes associated with infections caused by vancomycin-resistant enterococci in the United States: Systematic literature review and meta-analysis. Infect Control Hosp Epidemiol 2017;38(2):203-15. [Crossref] google scholar
25. 25. Xanthopoulou K, Peter S, Tobys D, Behnke M, Dinkelacker AG, Eisenbeis S, et al. Vancomycin-resistant Enterococcus faecium colonizing patients on hospital admission in Germany: prevalence and molecular epidemiology. J Antimicrob Chemother 2020;75(10):2743-51. [Crossref] google scholar
26. 26. Durante-Mangoni E, Andini R, Zampino R. Management of carbapenem-resistant Enterobacteriaceae infections. Clin Microbiol Infect 2019;25(8):943-59. [Crossref] google scholar
27. 27. Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob 2017;16(1):18. [Crossref] google scholar
28. 28. Kuş H, Arslan U, Türk Dağı H, Fındık D. Hastane enfeksiyonu etkeni Klebsiella pneumonia izolatlarında çeşitli virülans faktörlerinin araştırılması. [Investigation of various virulence factors of Klebsiella pneumoniae strains isolated from nosocomial infections]. Mikrobiyol Bul 2017;51(4):329-39. [Crossref] google scholar
29. 29. Mills JP, Talati NJ, Alby K, Han JH. The epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization and infection among long-term acute care hospital residents. Infect Control Hosp Epidemiol 2016;37(1):55-60. [Crossref] google scholar
30. 30. Yan L, Sun J, Xu X, Huang Sh. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital. Antimicrob Resist Infect Control 2020;9(1):155. [Crossref] google scholar
31. 31. Aktaş F. Gram negative bakterilerin hastane infeksiyonlarındaki rolü ve epidemiyolojisi. Ulusoy S, Leblebicioğlu H, Arman D, 2. baskı, Bilimsel Tıp Yayınevi, Ankara, Türkiye, 2012, p:183-206. google scholar
32. 32. Esen N. Acinetobacter ve non-fermentatif çomaklar. Topçu AW, Söyletir G, Doganay M, editörler. İnfeksiyon hastalıkları ve mikrobiyoloji. 4. baskı, İstanbul: Nobel Tıp Kitapevleri, İstanbul-Turkiye. 2017, p:1916-24. google scholar
33. 33. Ambretti S, Bassetti M, Clerici P, Petrosillo N, Tumietto F, Viale P, et al. Screening for carriage of carbapenem-resistant Enterobacteriaceae in settings of high endemicity: a position paper from an Italian working group on CRE infections. Antimicrob resist infect control 2019;13(8):136. [Crossref] google scholar